DAPOFORCE – Potency Product | Buy in Ukraine with Delivery

What is DAPOFORCE?

DAPOFORCE is a pharmaceutical drug belonging to the pharmacological group of phosphodiesterase type 5 (PDE-5) inhibitors. Its primary purpose is to restore and maintain erectile function in men facing difficulties achieving or maintaining an erection sufficient for satisfactory sexual intercourse. The medication is produced in the form of film-coated tablets, ensuring convenient oral administration and accurate dosing. The manufacturer of DAPOFORCE utilizes modern active substance purification technologies, guaranteeing high bioavailability and a predictable therapeutic effect. The pharmacological action of the drug is aimed at relaxing the smooth muscles of the penile blood vessels, which promotes increased blood flow into the cavernous bodies.

The mechanism of action of DAPOFORCE is based on the selective inhibition of the phosphodiesterase type 5 enzyme, which is responsible for the degradation of cyclic guanosine monophosphate (cGMP) in the cavernous bodies. During sexual stimulation, nitric oxide is released from nerve endings, activating the enzyme guanylate cyclase and increasing cGMP levels. The accumulation of cGMP leads to the relaxation of smooth muscles in the arteries supplying blood to the penis and increases blood inflow. It is important to understand that DAPOFORCE does not cause an erection directly — it enhances the natural physiological response to sexual arousal. That is why the drug is effective only in the presence of adequate sexual stimulation.

DAPOFORCE has proven itself as a reliable agent for men of various ages who suffer from erectile dysfunction of organic, psychogenic, or mixed origin. The drug is characterized by a rapid onset of action and a long-lasting therapeutic effect, allowing patients to plan sexual activity without unnecessary rush. Clinical studies have confirmed high efficacy and a favorable safety profile when following the recommended doses. Before starting DAPOFORCE, it is imperative to consult a physician, as erectile dysfunction may be an early symptom of cardiovascular disease or endocrine disorders. An individual's reaction to the drug may vary depending on age, concomitant diseases, and lifestyle.

What is DAPOFORCE prescribed for?

The main indication for the use of DAPOFORCE is erectile dysfunction, defined as the inability to achieve or maintain an erection sufficient for satisfactory sexual performance. This condition can stem from various causes: ranging from psychological factors such as stress, anxiety, or depression, to organic disorders associated with vascular, neurological, or hormonal diseases. DAPOFORCE effectively helps men regain confidence in their abilities and improve the quality of their intimate life. The medication is particularly useful for patients in whom erectile dysfunction is combined with diabetes mellitus, hypertension, or vascular atherosclerosis.

DAPOFORCE is also prescribed to men with psychogenic erectile dysfunction, where erectile impairment occurs against a background of psycho-emotional tension, fear of failure, or relationship conflicts. In such cases, the drug acts as a kind of "bridge," allowing the break of the vicious cycle of anxiety and failure, restoring the natural cycle of sexual response. Furthermore, DAPOFORCE may be recommended for patients who have undergone radical prostatectomy or radiation therapy of the pelvic organs, when erectile function is impaired due to damage to neural pathways. In such clinical situations, the medication helps maintain blood supply to the cavernous bodies and prevents fibrotic changes.

Another important indication is premature ejaculation, which frequently accompanies erectile dysfunction or arises as an independent disorder. Although DAPOFORCE is not a first-line drug for the treatment of premature ejaculation, its ability to maintain a stable erection allows a man to better control the moment of ejaculation. In the complex therapy of erectile dysfunction and premature ejaculation, DAPOFORCE demonstrates a synergistic effect, improving overall sexual function. The medication is also used in men with age-related androgen deficiency, when decreased testosterone levels are accompanied by worsening erectile function, but only after appropriate hormonal correction.

Composition and active components of DAPOFORCE

The active substance of DAPOFORCE is dapofil — a synthetic compound belonging to the class of selective phosphodiesterase type 5 inhibitors. Dapofil is structurally similar to other representatives of this group, but has certain pharmacokinetic features that provide a faster onset of action and a longer elimination half-life. After oral administration, dapofil is rapidly absorbed from the gastrointestinal tract, reaching maximum plasma concentration in approximately 60–90 minutes. The bioavailability of the drug is about 80%, which is a high indicator for medicinal products in this group. Dapofil metabolism occurs predominantly in the liver with the participation of cytochrome P450 system enzymes, particularly the CYP3A4 isoenzyme.

Excipients of DAPOFORCE include microcrystalline cellulose, which serves as a filler and ensures tablet stability, croscarmellose sodium as a disintegrant that promotes rapid disintegration of the tablet in the stomach, and magnesium stearate as a lubricant to prevent powder from sticking to the compressing equipment. The film coating contains hypromellose, titanium dioxide, and colorants that protect the active substance from moisture and light. This composition of inactive ingredients provides an optimal release profile for dapofil and minimizes the risk of gastric mucosa irritation.

The mechanism of action of dapofil consists in the selective inhibition of phosphodiesterase type 5, which leads to an increase in intracellular concentration of cGMP in the vascular smooth muscle cells of the penis. This causes relaxation of the vascular wall, vasodilation, and increased blood engorgement of the cavernous bodies. Importantly, dapofil has a significantly lower affinity for other phosphodiesterase isoforms, particularly PDE-6 found in the retina of the eye, which reduces the risk of color vision disturbances compared to some other drugs. Additionally, dapofil does not directly affect libido or hormonal status, merely modulating the vascular response to sexual stimulation.

DAPOFORCE Dosage

The standard recommended dose of DAPOFORCE for adult men is 50 mg once daily, taken approximately 30–60 minutes prior to anticipated sexual activity. Depending on individual efficacy and tolerability of the drug, the dose may be increased to a maximum of 100 mg or reduced to 25 mg. Dose adjustment is performed by a physician based on an assessment of the therapeutic response and the presence of side effects. The maximum recommended frequency of taking DAPOFORCE is no more than once a day, as exceeding this frequency does not increase efficacy but elevates the risk of adverse reactions. The drug is not intended for continuous daily use unless recommended by a doctor as part of a special therapeutic regimen.

For elderly patients (over 65 years of age), dose adjustment of DAPOFORCE is usually not required; however, a potential decrease in liver and kidney function should be taken into account, which may slow down the elimination of the drug. In patients with mild to moderate hepatic impairment, it is recommended to start therapy with a dose of 25 mg, and, if necessary, gradually increase it under medical supervision. In severe hepatic impairment, the use of DAPOFORCE is contraindicated due to the risk of drug accumulation and the development of toxic effects. Patients with severe renal impairment are also recommended a reduced starting dose of 25 mg.

The duration of the treatment course with DAPOFORCE is determined individually depending on the cause of erectile dysfunction and clinical response. In most cases, the medication is used on demand, that is, immediately before sexual intercourse, without the need for long-term continuous intake. However, in patients with chronic erectile dysfunction associated with vascular diseases or postoperative conditions, a doctor may recommend a course of low-dose intake to restore endothelial function. It is important not to exceed the recommended dose and not to take the drug more often than once a day, even if the effect seems insufficient.

How to take DAPOFORCE correctly?

DAPOFORCE is taken orally, regardless of food intake; however, it should be kept in mind that fatty food may delay the absorption of the drug and postpone the onset of action by 30–60 minutes. To achieve optimal results, it is recommended to take the tablet 30–60 minutes before planned sexual activity with a sufficient amount of water. The tablet should be swallowed whole, without chewing or crushing, as breaking the integrity of the film coating may alter the release rate of the active substance. The therapeutic effect of DAPOFORCE can persist for up to 12–24 hours after administration, allowing the patient not to tie sexual intercourse to an exact time of drug ingestion.

If a patient missed a dose of DAPOFORCE but plans sexual activity, he should take the medication as soon as he remembers, provided that at least 24 hours have passed since the previous intake. Do not double the dose to make up for a missed one, as this increases the risk of side effects without improving the therapeutic result. DAPOFORCE is non-addictive and does not accumulate in the body when following the recommended dosing schedule. The drug should not be taken together with grapefruit juice, as components of grapefruit can inhibit liver enzymes involved in the metabolism of dapofil and increase its blood concentration.

Before initiating DAPOFORCE, the patient must undergo a medical examination to rule out contraindications and evaluate cardiovascular risk. It is important to inform the doctor about all medications the patient takes regularly, especially nitrates, antihypertensive drugs, and anticoagulants. DAPOFORCE does not protect against sexually transmitted infections; therefore, barrier methods of contraception should be used during casual sexual contact. If an erection lasts longer than 4 hours or is accompanied by pain, seek immediate medical attention, as this may indicate the development of priapism — a condition threatening irreversible damage to penile tissues.

DAPOFORCE Side Effects

The most common side effects of DAPOFORCE are headache, flushing of the face and neck, nasal congestion, and dyspeptic symptoms such as nausea or a feeling of heaviness in the stomach. These reactions are usually mild to moderate, occurring primarily at the start of therapy and diminishing with continued use of the drug. Headache is associated with vasodilation of cerebral vessels, while nasal congestion is due to the expansion of blood vessels in the nasal mucosa. Dyspeptic symptoms can be minimized by taking the medication after a light meal. Most patients tolerate DAPOFORCE well, and the rate of drug discontinuation due to side effects is low.

Uncommon adverse reactions to DAPOFORCE include dizziness, impaired color vision (predominantly in the blue-green spectrum), muscle pain, and back pain. Muscle pain typically occurs 12–24 hours after taking the drug and resolves spontaneously within 48 hours. Visual disturbances are associated with a slight effect of dapofil on phosphodiesterase type 6 in the retina, but these phenomena are transient. In rare cases, palpitations, increased blood pressure, or allergic reactions such as skin rash and itching may occur. Patients with cardiovascular diseases should be particularly attentive to any unusual symptoms while taking the medication.

Rare but serious side effects of DAPOFORCE are priapism — a prolonged, painful erection not associated with sexual stimulation lasting more than 4 hours, as well as sudden loss of vision or sudden loss of hearing. These conditions require immediate medical intervention, as delay can lead to irreversible consequences. Cases of non-arteritic anterior ischemic optic neuropathy, manifested by a sudden decrease in visual acuity in one or both eyes, have also been described. Patients with risk factors for vascular diseases, such as hypertension, diabetes mellitus, smoking, or hyperlipidemia, have an increased risk of developing such complications. If any alarming symptoms appear, stop taking the medication immediately and consult a doctor.

DAPOFORCE Contraindications

An absolute contraindication to the use of DAPOFORCE is the concomitant use of nitrates in any form — tablet, sublingual, transdermal, or inhaled. Nitrates are frequently prescribed to patients with angina pectoris to relieve chest pain attacks, and combining them with PDE-5 inhibitors can cause a critical drop in blood pressure leading to collapse. DAPOFORCE is also contraindicated in patients with hypersensitivity to dapofil or any inactive component of the formulation. A history of allergic reactions to other PDE-5 inhibitors requires extreme caution when prescribing DAPOFORCE. The drug is not used in patients with severe hepatic impairment and end-stage renal disease requiring hemodialysis.

DAPOFORCE is contraindicated in men with cardiovascular diseases for whom sexual activity is inadvisable: recent myocardial infarction (within the last 90 days), unstable angina, NYHA Class II–IV heart failure, uncontrolled arterial hypertension, or hypotension. The drug is also not prescribed to patients with hereditary degenerative retinal disorders, such as retinitis pigmentosa, as there is a theoretical risk of worsening visual functions. For men who have suffered a stroke or transient ischemic attack within the past 6 months, the use of DAPOFORCE is contraindicated due to an increased risk of recurrent vascular events.

Special patient groups require separate consideration. Pregnancy and lactation are not relevant for DAPOFORCE, as the drug is intended exclusively for men and its use by women is not envisioned. Children and adolescents under 18 years of age should not use DAPOFORCE due to the lack of safety and efficacy data in this age group. Elderly patients can use the drug without dose adjustment; however, the higher risk of concomitant diseases and interactions with other medications should be considered. In patients with penile deformities, such as Peyronie's disease or cavernosal angiofibrosis, DAPOFORCE is prescribed with caution due to the increased risk of developing priapism.

Interaction of DAPOFORCE with other drugs and alcohol

The most dangerous drug interaction of DAPOFORCE is its combination with nitrates and nitric oxide donors, such as nitroglycerin, isosorbide dinitrate, isosorbide mononitrate, amyl nitrite, and others. The co-administration of these drugs leads to synergistic vasodilation and a critical drop in blood pressure, which can be life-threatening. DAPOFORCE also enhances the hypotensive effect of alpha-blockers used to treat benign prostatic hyperplasia or arterial hypertension. When used concurrently with alpha-blockers, it is recommended to start DAPOFORCE therapy at a minimum dose of 25 mg and monitor blood pressure carefully. Inhibitors of the CYP3A4 enzyme, such as ketoconazole, itraconazole, erythromycin, and ritonavir, can increase dapofil concentrations in the blood; therefore, with their co-administration, the dose of DAPOFORCE should be reduced.

The consumption of alcohol while taking DAPOFORCE is not strictly contraindicated; however, it should be noted that alcohol itself can impair erectile function and exacerbate side effects of the drug, such as dizziness, headache, and orthostatic hypotension. Excessive alcohol consumption significantly reduces the efficacy of DAPOFORCE, as ethanol depresses the central nervous system and decreases sexual arousal. It is recommended to limit alcohol intake to minimal amounts or avoid it completely on days of taking the medication. DAPOFORCE does not significantly affect the ability to drive vehicles; however, if dizziness or visual disturbances occur, one should refrain from driving a car and operating machinery until symptoms completely disappear.

Where to buy DAPOFORCE in Ukraine

DAPOFORCE is available in pharmacy chains in Ukraine by doctor's prescription, as it belongs to prescription-only medicines. Purchasing the drug requires prior consultation with a urologist, andrologist, or family doctor, who will assess the appropriateness of use and issue a prescription. This approach ensures patient safety and avoids the unwanted consequences of self-medication. The cost of DAPOFORCE may vary depending on the dosage, the number of tablets in the package, and the pricing policy of a specific pharmacy. Patients are advised to compare prices across different pharmacy chains, as the difference can be substantial.

Many pharmacies offer the option of online ordering of DAPOFORCE with subsequent self-pickup or courier delivery, which is especially convenient for patients who value confidentiality. The drug should be stored in its original packaging at a temperature not exceeding 25 °C in a dry place, protected from light and inaccessible to children. The shelf life of DAPOFORCE is typically 3 years from the date of manufacture, and the drug should not be used after its expiration. Before using DAPOFORCE, be sure to read the full medical instructions and consult a doctor, as an individual's reaction to the drug may vary depending on health status, age, and concomitant therapy.